BioAmber to Supply Biobased Succinic Acid to Mitsubishi Chemical

BioAmber, a renewable chemistry firm, has signed strategic agreement with Mitsubishi Chemical to supply of biobased succinic acid.

Under the terms of the agreement, BioAmber and Mitsui, a distribution partner of BioAmber, will supply succinic acid to Mitsubishi Chemical. BioAmber, Mitsui and Mitsubishi Chemical are jointly performing a feasibility study to construct a succinic acid manufacturing plant in Thailand.

The succinic acid technology of Mitsubishi will be integrated with bio-based succinic platform. The main objective of the partnership is to generate low-cost succinic acid, which in turn will help reduce the manufacturing cost of polybutylene succinate (PBS). PBS is a biodegradable and renewable polymer produced by Mitsubishi Chemical.

BioAmber has started the supply of biobased succinic acid manufactured in Europe and has received rights to use Mitsubishi Chemical’s PBS for advanced PBS polymers. These polymers are distributed via BioAmber's subsidiary, Sinoven Biopolymers.

The world-class succinic acid technology from BioAmber will reduce the cost of biobased PBS and will make the material more than 50% renewable. In addition, the partnership will hasten the PBS sales growth.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). BioAmber to Supply Biobased Succinic Acid to Mitsubishi Chemical. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=28949.

  • MLA

    Chai, Cameron. "BioAmber to Supply Biobased Succinic Acid to Mitsubishi Chemical". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=28949>.

  • Chicago

    Chai, Cameron. "BioAmber to Supply Biobased Succinic Acid to Mitsubishi Chemical". AZoM. https://www.azom.com/news.aspx?newsID=28949. (accessed November 23, 2024).

  • Harvard

    Chai, Cameron. 2019. BioAmber to Supply Biobased Succinic Acid to Mitsubishi Chemical. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=28949.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.